Advice
Search strategy and evidence selection (economic)
Embase 1980 to 2014 Week 34, Ovid MEDLINE In‑Process & Other Non‑Indexed Citations and Ovid MEDLINE 1946 to Present. Searched on 4 September 2014
1. prostate.mp.
2. brachytherapy.mp. or Brachytherapy/
3. HDR.mp.
4. High Dose Rate.mp.
5. real‑time ultrasound.mp.
6. OnCentra.mp.
7. Nucletron.mp.
8. 2 or 3 or 4 or 5 or 6 or 7
9. cost*.mp.
10. economic*.mp.
11. 9 or 10
12. 1 and 8 and 11
13. limit 12 to English language
14. limit 13 to year="2007 ‑Current"
15. limit 14 to humans
16. remove duplicates from 15
Cochrane Database of Systematic Reviews Issue 9 of 12, September 2014
Cochrane Central Register of Controlled Trials Issue 8 of 12, August 2014
1. Oncentra or HDR Brachytherapy
2. Prostate Cancer
3. cost* or economic*
4. #1 and #2 and #3
DARE (Database of Abstracts of Reviews of Effects), NHS EED (National Health Service Economic Evaluation Database), and HTA (Health Technology Assessment) databases; Searched on 4 September 2014
(Oncentra or HDR Brachytherapy ) AND (Prostate Cancer ) AND (cost* or economic* ) IN DARE, NHSEED, HTA FROM 2007 TO 2014
Evidence selection (economic)
Total abstracts: 239
Duplicates: 1
Abstracts reviewed: 238
Full papers reviewed: 0
Exclusion criteria: case studies, editorials, letters, reviews, conference proceedings/abstracts, animal studies, non‑English language studies, not using the Oncentra Prostate.
Studies for review: 0